EN
登录

医疗设备研发商CDX Medical Technologies获得250万美元A轮融资,推动ECMO创新

CDX Medical Technologies Secures $2.5M Series A Funding Led by Joe Kiani to Advance ECMO Innovation

CISION 等信源发布 2025-07-14 23:04

可切换为仅中文


BOSTON

波士顿

,

July 14, 2025

2025年7月14日

/PRNewswire/ -- CDX Medical Technologies (CDX), a pioneer in extracorporeal membrane oxygenation (ECMO) pump innovation, today announced the successful close of its

/PRNewswire/ -- CDX医疗技术公司(CDX),体外膜肺氧合(ECMO)泵创新的先驱,今天宣布成功完成了其

$2.5 million

250万美元

Series A funding round. The round was led by

A轮融资。本轮融资由

Joe Kiani

乔·基亚尼

, Founder of Masimo and a world-renowned health technology entrepreneur, with participation from leading industry executives and the CDX Board of Directors. Kiani, who also founded Willow Laboratories and co-founded Like Minded Labs, will join the CDX Board.

,Masimo创始人以及世界知名的健康技术企业家,参与的还有行业高管和CDX董事会成员。Kiani还创立了Willow Laboratories并共同创立了Like Minded Labs,他将加入CDX董事会。

This investment enables CDX to complete regulatory testing, secure market approval and initiate commercialization.

这项投资使CDX能够完成监管测试、获得市场批准并启动商业化。

Welcoming Joe to the Board, Co-CEO Dr.

欢迎乔加入董事会,联席首席执行官博士。

Gopal K. Chopra

高帕尔·K·乔帕

stated, 'We are thrilled to have Joe on the CDX team. Joe brings a wealth of experience and insight into the world of respiratory care and intelligent medical devices. His investment and contributions at the Board level will significantly assist the company in creating a new market and disrupting respiratory care to the benefit of patients worldwide.

表示:“我们很高兴乔加入CDX团队。乔在呼吸护理和智能医疗设备领域带来了丰富的经验和洞察力。他在董事会层面的投资和贡献将大大帮助公司开拓新市场,颠覆呼吸护理领域,造福全球患者。

Joe's enthusiasm for impactful innovation and his commitment to patient safety and care will be transformative.'.

乔对有影响力的创新的热情以及他对患者安全和护理的承诺将会带来变革。

Co-CEO

联合首席执行官

Rick Smith

瑞克·史密斯

added, 'Joe's involvement brings the expertise to navigate the global landscape of medical devices and strategic insight into growing markets.'

补充道:“乔的参与带来了驾驭全球医疗器械领域和对增长市场战略洞察的专业知识。”

'ECMO is a lifesaving solution, but today it takes too much from our valued resources and therefore it's only provided to a few. CDX is revolutionizing ECMO by making it not just small and portable, but by practically automating it. The CDX platform will benefit respiratory failure patients worldwide in an area that has needed disruption,' said .

“ECMO是一项挽救生命的技术,但如今它耗费了我们大量宝贵资源,因此仅能提供给少数人使用。CDX通过使其不仅小巧便携,还几乎实现自动化,正在彻底改变ECMO的应用。CDX平台将为全球呼吸衰竭患者带来福音,这是一个亟需革新的领域,”他表示。

Joe Kiani

乔·基亚尼

.

Dr.

博士

Hugh Cassiere

休·卡西尔

, Director of Critical Care, Cardiac Services at South Shore University Hospital of Northwell Health and current chair of the FDA's Anesthesiology and Respiratory Therapy Devices panel, added, 'CDX is providing a much-needed innovation where nothing exists. The company has demonstrated its commitment to innovation and incorporating the clinical need, and we are very excited to be a lead potential site for the commercial release.'.

南岸大学医院(Northwell Health)重症监护、心脏服务部主任,同时也是FDA麻醉学和呼吸治疗设备小组现任主席补充道:“CDX正在提供一项急需的创新,填补了当前的空白。该公司已经展示了其对创新的承诺,并且充分考虑了临床需求,我们非常兴奋能够成为商业发布的领先潜在站点。”

CDX has long been at the forefront of clinical conversation around lung failure and lung recovery. Following extensive bench and in vivo testing, the company is preparing to submit its proprietary pump for regulatory approval for use in ECMO. The new funding will support completion of submission testing, early commercial development and team expansion..

CDX长期以来一直处于关于肺衰竭和肺恢复的临床讨论前沿。经过广泛的台架试验和体内测试,该公司正准备提交其专有泵以获取监管批准用于ECMO。新的资金将支持完成提交测试、早期商业开发和团队扩展。

About CDX Medical Technologies, LLC

关于CDX医疗技术有限责任公司

CDX is a medical device innovation company focused on the novel development of a pump for ECMO and building a platform for respiratory care. CDX is building a much-needed solution for both acute and chronic lung care and has received recognition at major conferences, including winning the THT Shark Tank 2024 hosted by the Cardiac Research Foundation (CRF)..

CDX是一家医疗设备创新公司,专注于ECMO泵的新型开发,并构建呼吸护理平台。CDX正在打造一个针对急性和慢性肺部护理的迫切需要的解决方案,并在包括由心脏研究基金会(CRF)主办的THT Shark Tank 2024在内的主要会议上获得了认可。

Media Contact:

媒体联系人:

Jackie Dadas-Kraper, Vice President of PR

杰基·达达斯-克拉珀,公关副总裁

Interdependence

互依性

2488420597

2488420597

397927@email4pr.com

397927@email4pr.com

SOURCE CDX Medical Technologies

来源:CDX医疗技术

WANT YOUR COMPANY'S NEWS

想要你公司的新闻吗

FEATURED ON PRNEWSWIRE.COM?

刊登在PRNEWSWIRE.COM上?

440k+

44万+

Newsrooms &

新闻编辑室 &

Influencers

影响者

9k+

9k+

Digital Media

数字媒体

Outlets

插座

270k+

27万+

Journalists

记者

Opted In

已选择加入

GET STARTED

开始使用